Efficacy of 4'-[methyl-11C] thiothymidine PET/CT before and after neoadjuvant therapy for predicting therapeutic responses in patients with esophageal cancer: a pilot study.
Masatoshi HottaRyogo MinamimotoKazuhiko YamadaKyoko NoharaDaisuke SomaKazuhiko NakajimaJun ToyoharaKei TakasePublished in: EJNMMI research (2019)
4DST PET/CT has a great potential for predicting pathologic response to neoadjuvant therapy in patients with esophageal cancer; it may be slightly superior to that with FDG PET/CT.